Overview

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Status:
Recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen suppression is not completely understood. This study will compare the use of hypofraction proton therapy (28 treatments) alone to proton therapy with androgen suppression therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Proton Collaborative Group
Treatments:
Androgens
Ascorbic Acid
Buserelin
Estrogens, Conjugated (USP)
Goserelin
Leuprolide
Methyltestosterone
Triptorelin Pamoate